The Squad Has a Meltdown Over Pro-Terrorism Encampments Getting Dismantled
New Polling Shows the Left's Climate Change Hysteria Losing Steam
Joe Biden Just Lost Another Battle With His Teleprompter
Biden's Use of TikTok Cited to Support Company's Lawsuit Against the Government
Police Officer Stuck in BLM Nightmare
Speaker Mike Johnson Gets to Keep His Job
Prosecutor Leading Stormy Daniels Questioning In Trump Trial Is a Major Biden Donor
Trump Finds Brilliant Way to Sidestep Judge Merchan's Unconstitutional Gag Order
Lloyd Austin Confirms Delay in Aid to Israel: 'We’ve Paused One Shipment of...
Here’s Why This Democrat Rep Thinks NPR Is 'Necessary’ for Americans
Department of Education's Move Forces Jewish Groups to Pull Out of Meeting
Sickening: 'Newcomer' Illegal Immigrant Arrested in Florida for Heinous Crime
The IRA Is Punishing Small Businesses and Putting Cancer Patients at Risk
House Dems Are Asking for Executive Action on the Border, but KJP of...
Boeing Cargo Plane Forced to Make Emergency Landing After Gear Fails
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos